113 related articles for article (PubMed ID: 6467189)
21. Combination of perfluorochemical emulsions and carbogen breathing with cancer chemotherapy.
Teicher BA
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1109-20. PubMed ID: 7849913
[TBL] [Abstract][Full Text] [Related]
22. Use of perfluorochemical emulsions in cancer therapy.
Teicher BA
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):875-82. PubMed ID: 1391527
[TBL] [Abstract][Full Text] [Related]
23. New high O2 carrying perfluorochemical emulsions and/or carbogen: reactions of a human tumor xenograft to irradiation.
Thomas C; Lartigau E; Malaise EP; Guichard M
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1157-60. PubMed ID: 2497094
[TBL] [Abstract][Full Text] [Related]
24. Lack of radiosensitization in Lewis lung carcinoma and a murine plasmacytoma by MTDQ and MTDQ-DA.
Schlappack OK; Peacock JH; Haslinger RK; Schmidt WF; Eady JJ
Strahlenther Onkol; 1988 Nov; 164(11):684-8. PubMed ID: 3201385
[TBL] [Abstract][Full Text] [Related]
25. Effect of oxygen level on the enhancement of tumor response to radiation by perfluorochemical emulsions or a bovine hemoglobin preparation.
Teicher BA; Herman TS; Hopkins RE; Menon K
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):969-74. PubMed ID: 1917627
[TBL] [Abstract][Full Text] [Related]
26. Perfluorochemical emulsions: oxygen breathing in radiation sensitization and chemotherapy modulation.
Teicher BA; Herman TS; Frei E
Important Adv Oncol; 1992; ():39-59. PubMed ID: 1582677
[No Abstract] [Full Text] [Related]
27. Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents.
Teicher BA; Holden SA
Cancer Treat Rep; 1987 Feb; 71(2):173-7. PubMed ID: 3100035
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of fractionated radiation therapy by an experimental concentrated perflubron emulsion (Oxygent) in the Lewis lung carcinoma.
Teicher BA; Herman TS; Menon K
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):899-902. PubMed ID: 1391530
[TBL] [Abstract][Full Text] [Related]
29. Response of subpopulations of the FSall C fibrosarcoma to low dose x-rays and various potential enhancing agents.
Tanaka J; Holden SA; Herman TS; Teicher BA
Anticancer Res; 1992; 12(3):1029-33. PubMed ID: 1622113
[TBL] [Abstract][Full Text] [Related]
30. Radiosensitization of hypoxic tumor cells by dodecafluoropentane: a gas-phase perfluorochemical emulsion.
Koch CJ; Oprysko PR; Shuman AL; Jenkins WT; Brandt G; Evans SM
Cancer Res; 2002 Jul; 62(13):3626-9. PubMed ID: 12097264
[TBL] [Abstract][Full Text] [Related]
31. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN
Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483
[TBL] [Abstract][Full Text] [Related]
32. Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors.
Rodrigues LM; Howe FA; Griffiths JR; Robinson SP
J Magn Reson Imaging; 2004 Apr; 19(4):482-8. PubMed ID: 15065173
[TBL] [Abstract][Full Text] [Related]
33. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054
[TBL] [Abstract][Full Text] [Related]
34. Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
Teicher BA; Holden SA; Rose CM
J Natl Cancer Inst; 1985 Dec; 75(6):1129-33. PubMed ID: 3934448
[TBL] [Abstract][Full Text] [Related]
35. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
Ohizumi Y; Lam GK; Pickles T; Fryer C; Chaplin DJ
Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
[TBL] [Abstract][Full Text] [Related]
36. [Radiosensitization effects of perfluorochemical emulsion to LLC tumor mice with fractionated irradiation under oxygen breathing and radiotoxicity to normal mice].
Itoh YH; Ayakawa Y; Miyata N
Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Dec; 47(12):1588-95. PubMed ID: 3452792
[No Abstract] [Full Text] [Related]
37. Acute effects of a perfluorochemical oxygen carrier on normal tissues of the mouse.
Mason KA; Withers HR; Steckel RJ
Radiat Res; 1985 Dec; 104(3):387-94. PubMed ID: 4080982
[TBL] [Abstract][Full Text] [Related]
38. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin.
Sun JR; Brown JM
Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model.
Luo X; Slater JM; Gridley DS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):553-64. PubMed ID: 15964154
[TBL] [Abstract][Full Text] [Related]
40. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
